Syngene International Limited
NSE: SYNGENE · Healthcare
₹406.40
+7.85 (+1.97%)
Last close · 30 Aug 2026, 11:12 am IST
- Open
- ₹398.55
- Day high
- ₹407.00
- Day low
- ₹396.25
- Volume
- 3.99 L
- Prev close
- ₹398.55
HealthcareDiagnostics & ResearchPart of:All NSE StocksNifty 500Nifty HealthcareNifty Midcap 150Nifty MidSmallcap 400
Price chart
Range
EMA
Also show
Fundamentals
Diagnostics & Research
Valuation
- Market Cap
- 16,368 Cr
- Price
- 406.65
- P/E (TTM)
- 51.54
- P/E (Fwd)
- 32.26
- P/B
- 3.38
- EV/EBITDA
- 16.69
- EV/Revenue
- 4.15
- PEG
- —
- Div Yield
- 0.31%
- 52W High
- 728.60
- 52W Low
- 380.00
- Beta
- -0.00
Profitability & income
- Revenue (TTM)
- 3,739 Cr
- Net Income (TTM)
- 317 Cr
- EBITDA
- 930 Cr
- Gross Margin
- 68.00%
- Op. Margin
- 20.82%
- Net Margin
- 8.47%
- ROE
- 6.62%
- ROA
- 4.78%
- EPS (TTM)
- 7.89
- EPS (Fwd)
- 12.60
Financial health
- Total Debt
- 458 Cr
- Total Cash
- 1,289 Cr
- Debt/Equity
- 9.47
- Current Ratio
- 1.38
- Quick Ratio
- 1.18
- Book Value
- 120.41
- Free Cash Flow
- 728 Cr
- Op. Cash Flow
- 915 Cr
Growth
- Revenue Growth
- 1.80%
- Earnings Growth
- -19.40%
- Earnings QoQ
- -19.30%
Quarterly results
| Period | Revenue | Net Income | EBITDA | Op. Income | Gross Profit | Op. Cash Flow | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 1,037 Cr | 148 Cr | 320 Cr | 213 Cr | 803 Cr | — | 458 Cr | 4,839 Cr |
| 2025-12-31 | 917 Cr | 15 Cr | 154 Cr | 119 Cr | 688 Cr | — | — | — |
| 2025-06-30 | 875 Cr | 87 Cr | 224 Cr | 100 Cr | 657 Cr | — | — | — |
| 2025-03-31 | 1,018 Cr | 183 Cr | 363 Cr | 242 Cr | 783 Cr | — | 578 Cr | 4,727 Cr |
| 2024-12-31 | 944 Cr | 131 Cr | 302 Cr | 173 Cr | 706 Cr | — | — | — |
Annual results
| Period | Revenue | Net Income | EBITDA | Op. Income | Gross Profit | Op. Cash Flow | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 3,611 Cr | 317 Cr | 909 Cr | 557 Cr | 2,692 Cr | 915 Cr | 458 Cr | 4,839 Cr |
| 2025-03-31 | 3,513 Cr | 496 Cr | 1,142 Cr | 613 Cr | 2,570 Cr | 1,168 Cr | 578 Cr | 4,727 Cr |
| 2024-03-31 | 3,370 Cr | 510 Cr | 1,092 Cr | 647 Cr | 2,439 Cr | 1,042 Cr | 555 Cr | 4,258 Cr |
| 2023-03-31 | 3,080 Cr | 464 Cr | 995 Cr | 618 Cr | 2,220 Cr | 824 Cr | 815 Cr | 3,618 Cr |
| 2022-03-31 | — | — | — | — | — | — | — | — |
Figures in ₹ crore unless stated. Ratios and margins are trailing twelve months where marked TTM.
Want charts and signals for SYNGENE?
Sign in for candlestick charts with Supertrend, MACD and VWAP overlays, plus watchlists and email alerts.
Sign in